Clinical Trial Update: A Study of Picankibart in Patients With Active Psoriatic Arthritis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating a Phase 2/3 study of Picankibart in active psoriatic arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Picankibart

Snippet

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | Conditions: Psoriatic Arthritis | Phase 2, Phase 3 | Status: RECRUITING